Clinical Trials Browser

Adenocarcinoma, Carcinoma, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial

NCT02645149 2026-02-27

Match Mel

Phase 2 Completed

216 enrolled

Dermatologic

Melanoma

NCT04594187 2026-02-17

MelPORT

Phase 2 Recruiting

168 enrolled

Dermatologic

Melanoma

NCT06943235 2026-02-11

Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC)

Phase 2 Recruiting

60 enrolled

Thoracic

Limited Stage Small Cell Lung Cancer

NCT07397442 2026-02-11

Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer

Phase 2 Not yet recruiting

19 enrolled

Gastrointestinal

Pathologic Complete Response, Rectal Neoplasms

NCT06610734 2026-02-09

SKY

Phase 2 Recruiting

202 enrolled

Thoracic

Small Cell Lung Cancer Extensive Stage

NCT06810609 2026-01-27

InDuRanS

Phase 2 Recruiting

176 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05978193 2026-01-22

SCR-ESCC-01

Phase 2 Recruiting

100 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT07333287 2026-01-12

A Multicenter Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Embolization Combined With Dual Immune Checkpoint Inhibitors.

Phase 2 Not yet recruiting

38 enrolled

Gastrointestinal

Pancreatic Cancer Liver Metastases

NCT07259473 2026-01-07

Pre-CATALIS

Phase 2 Not yet recruiting

15 enrolled

Turcot syndrome

NCT07293247 2025-12-22

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

Phase 2 Not yet recruiting

164 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07297030 2025-12-22

SIB-RT Combined With CAPOX and PD-1 for High-Risk Rectal Cancer

Phase 2 Not yet recruiting

37 enrolled

Gastrointestinal

Rectal Neoplasms

NCT03614949 2025-12-19

SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer

Phase 2 Active not recruiting

21 enrolled

Gynecologic

Uterine Cervical Neoplasms

Clinical Trials

Grid Radiation Therapy for the Treatment of Stage IV Non-Small Cell Lung Cancer

Reduced CT + Anti-PD-1 as First Line Tx in Vulnerable Older Adults w/Adv <50% PD-L1 Non-Small Cell Lung Cancer (NSCLC)

Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer

Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer

ROWAN

Match Mel

MelPORT

Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC)

Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer

SKY

InDuRanS

SCR-ESCC-01

A Multicenter Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Embolization Combined With Dual Immune Checkpoint Inhibitors.

Pre-CATALIS

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

SIB-RT Combined With CAPOX and PD-1 for High-Risk Rectal Cancer

SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer